← Open Payments lookup

ANNA BALABAN: Open Payments

NPI 1750917076 · ATLANTA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,241 in 48 payments from 22 companies in 2025. Trend: 2023 $287 · 2024 $1,606 · 2025 $1,241

Food & beverage: $1,241
CompanyPaymentsAmount
AstraZeneca Pharmaceuticals LP7$279
Daiichi Sankyo Inc.5$117
Incyte Corporation4$103
Novartis Pharmaceuticals Corporation5$96
TerSera Therapeutics LLC2$69
GENZYME CORPORATION2$66
Merck Sharp & Dohme LLC2$56
Janssen Biotech, Inc.2$49
Exelixis Inc.2$48
Genentech USA, Inc.2$45

Products named: ENHERTU, DATROWAY, MONJUVI, Zoladex, SARCLISA, CABOMETYX, Vanflyta, LUTATHERA.

Industry payments across GA — which companies pay providers there.